Torii Pharmaceutical News

Torii Pharmaceutical: Matters relating to controlling shareholders, etc.

Mar 27 14:00

Torii Pharmaceutical: Articles of Incorporation 2024/03/27

Mar 27 12:10

Torii Pharmaceutical: Independent Officer Registration Form

Mar 4 16:00

Torii Pharmaceutical: Notice of receipt of communication regarding partial withdrawal of shareholder proposals

Feb 13 16:00

Torii Pharmaceutical: Notice regarding personnel affairs of executive officers, etc.

Feb 9 15:00

Torii Pharmaceutical: Notice regarding the opinions of the Board of Directors of the Company on shareholder proposals

Feb 9 15:00

Torii Pharmaceutical: Notice regarding partial changes to the Articles of Incorporation

Feb 9 15:00

Torii Pharmaceutical: Announcement of the update of the medium- to long-term business vision “VISION2030” calculation targets and formulation of the “Mid-Term Management Plan 2024-2026”

Feb 9 15:00

Torii Pharmaceutical: Conclusion of a license agreement for exclusive development and commercialization rights for GRAZAX, an allergen immunotherapy (sublingual immunotherapy) drug for poaceae hay fever in Japan

Dec 13, 2023 07:00

Torii Pharmaceutical: Matters relating to controlling shareholders, etc.

Mar 28, 2023 14:00

Torii Pharmaceutical: Articles of Incorporation 2023/03/28

Mar 28, 2023 12:11

Torii Pharmaceutical: Suggestions on the exercise of the right to vote in the Resolution of the General meeting of the Company's ISS Company's opinion on the report of the Company's General meeting

Mar 10, 2023 14:00

Torii Pharmaceutical: Notice on partial changes to the articles of association

Feb 10, 2023 14:00

Torii Pharmaceutical: Notice on the opinions of the board of directors of the company to the shareholders' proposal

Feb 10, 2023 14:00

Torii Pharmaceutical: Notice on personnel

Feb 10, 2023 14:00

Torii Pharmaceutical: Circular on the formulation of the medium-term Business Plan 2023-2025

Feb 10, 2023 14:00

Torii Pharmaceutical: Signing of the license agreement for the exclusive development and commercialization of Nogra's acne vulgaris treatment drug (NAC-GED-0507) in Japan

Jan 26, 2023 14:00

Torii Pharmaceutical Co Ltd: Matters relating to controlling shareholders, etc.

Mar 29, 2022 14:00

Torii Pharmaceutical Co Ltd: Articles of association 2022-03-29

Mar 29, 2022 12:39

Torii Pharmaceutical Co Ltd: Suggestions on the exercise of the right to vote in the Resolution of the General meeting of the Company's ISS Company's opinion on the report of the Company's General meeting

Mar 10, 2022 16:00